Our Mission
SMRTmeds is transforming vaccination by predicting individual immune responses with our causal ML technology. Over the next 5 to 10 years, we aim to support over one hundred million people by integrating into major healthcare systems worldwide. Our scalable licensing model helps providers such as the NHS and European healthcare agencies, and pharmaceutical partners, optimise vaccine usage, enhance immune protection, reduce costs, and strengthen preparedness for future pandemics.
